An incredible discovery that could revolutionise cancer treatment was made in March 2024.
The therapeutic experiment, which was used to treat glioblastoma, a deadly kind of brain cancer, showed “dramatic responses within days” for the trial participants.
A novel method to CAR-T therapy, a sophisticated and individualised treatment that triggers your immune system to attack the cancer cells, is being used by researchers and surgeons from the Mass General Brigham healthcare system.
Utilising the patient’s own immune system, CAR-T therapy is typically used to treat leukaemia. Before being returned to the patient and used to treat their ailment, a patient’s blood is usually extracted and sent to a laboratory to be “trained” to combat the cancer cells.